Herein, we suggested that the GSTP1 IIe105Val, GSTM1 and GSTT1 null or present genetic polymorphisms might be predictive factors for the efficacy of platinum-based chemotherapy to NSCLC patients. The gene discussed is GSTP1; the disease is non-small cell lung carcinoma.